Transfer Membrane Market (By Product: Nitrocellulose, PVDF, Nylon; By Transfer Method: Wet or Tank Transfer, Semi-dry Electro Blotting, Dry Electro Blotting, Others; By Application, Northern Blotting, Southern Blotting, Western Blotting, Others; By End-User: Academic & Research Institutes, Pharmaceutical & Biopharmaceutical Companies, Diagnostic Labs) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032

The global transfer membrane market size was exhibited at USD 419 million in 2022 and is projected to hit around USD 872.38 million by 2032, growing at a CAGR of 5.03% during the forecast period 2023 to 2032.

Key Pointers:

• North America has generated more than 39% of revenue share in 2022.
• Asia Pacific is predicted to grow at the quickest CAGR of 5.95% between 2023 and 2032.
• By Product, the PVDF segment captured more than 41% of revenue share in 2022.
• By Application, the western blotting has recorded for the highest revenue share in 2022.
• By End-User, the pharmaceutical and biopharmaceutical companies are predicted to generate the maximum market share between 2023 and 2032.

Transfer Membrane Market Report Scope

Transfer membranes are used as solid phase supports for transferring nucleic acids or proteins from gel matrices in various blotting technique. These membranes aid in the detection and analysis of specific proteins or nucleic acids and thus play an important role in the diagnosis of various diseases. Hence, demand for transfer membranes is expected grow in the near future owing to the high prevalence of infectious and genetic diseases. For instance, according  to HIV.gov, an estimated 1.5 million individuals worldwide acquired the HIV infection in 2021, while around 38.4 million individuals were suffering with the disease in the same year. Since western blotting technique is widely used as a confirmatory assay for the detection of HIV infection, the high demand for transfer membranes used in such assays is expected to fuel the market in the coming years.

The COVID-19 outbreak positively affected the market in 2020 and 2021 as transfer membranes were used in the clinical investigation and diagnostic applications for the disease. For instance, Western  blots were used as a confirmatory test for the positive or borderline-positive results from other screening tests. Similarly, Northern  blotting techniques were used in identification of various sub-genomes of the SARS-CoV-2 virus. In addition , by May 2021, the U.S. and Germany had invested more than USD 2.0 billion and USD 1.5 billion, respectively, in COVID-19 vaccine research and development activities which boosted growth of the life science research tools such as transfer membranes in 2021.

Moreover, the demand for transfer membranes is growing due to the increasing scope of application for various blotting techniques. For instance, the applications of Southern blotting can range from confirmatory assays for cloning or knockout experiments to clinical diagnostics involving the identification of gene mutations in diseases such as sickle cell anemia. Hence, with the increasing scope for expansion in the genetic engineering domain, adoption of transfer membranes for molecular biology experimentation is expected to grow during the forecast period.

Furthermore, transfer membranes are being increasingly used in the biopharmaceutical industry wherein protein purification and characterization form an important aspect of several research and development activities. For instance, during the drug development phases, transfer membranes form an essential part of the protein analysis workflows where they are used for separation of proteins for further staining procedures. In addition, the high investments in research and development activities by key biopharmaceutical companies are expected to drive the market growth. For instance, in 2021, F. Hoffmann-La Roche Ltd. had a research & development budget of around USD 16.1 billion, while Johnson & Johnson and Bristol Myers Squibb had a budget of about USD 14.7 billion and USD 11.3 billion, respectively.

However, techniques such as Western and Southern blotting have certain disadvantages which make them less preferable over other alternatives. For instance, these  techniques are labor intensive, require large quantities of samples & skilled personnel for carrying out the experiments, and incur high operational costs due to the expensive  antibodies and imaging equipment involved.

As a result, such techniques are being increasingly replaced by the technologies such as Enzyme-Linked Immunosorbent Assay (ELISA) and Polymerase Chain Reaction (PCR), which can offer better throughput and faster processing time at lower costs. As a result, with the increasing substitution of blotting techniques the usage of transfer membranes may also diminish, which may hinder the market growth during the forecast period.

Some of the prominent players in the Transfer Membrane Market include:

• Bio-Rad Laboratories
• Merck KGaA
• Santa Cruz Biotechnology, Inc.
• ATTO Corporation
• Thermo Fisher Scientific, Inc.
• Danaher
• Azure Bio systems Inc.
• Advansta Inc.
• GVS S.p.A.
• PerkinElmer, Inc.
• Abcam Plc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Transfer Membrane market.

By Product

• Nitrocellulose
• PVDF
• Nylon

By Transfer Method

• Wet or Tank Transfer
• Semi-dry Electro Blotting
• Dry Electro Blotting
• Others

By Application

• Northern Blotting
• Southern Blotting
• Western Blotting
• Others

By End-User

• Academic & Research Institutes
• Pharmaceutical & Biopharmaceutical Companies
• Diagnostic Labs

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)